
New HS treatment guidelines emphasize expanded biologic options, individualized care, and early intervention to prevent irreversible damage.

Harvard, NIH-trained dermatologist. Investigator and dermatologist with focus on hidradenitis suppurativa (HS). HS foundation president

New HS treatment guidelines emphasize expanded biologic options, individualized care, and early intervention to prevent irreversible damage.